Mast Cells as an Indicator and Prognostic Marker in Molecular Subtypes of Breast Cancer

In Vivo. 2019 May-Jun;33(3):743-748. doi: 10.21873/invivo.11534.

Abstract

Background/aim: Mast cells (MCs) represent the most controversial non-malignant element of the tumor microenvironment. Our aim was to study how MCs density and distribution (intratumoral-MCit versus peritumoral-MCpt) relate to tumor grade and molecular subtypes.

Materials and methods: MCs tryptase immunohistochemistry was performed on 80 cases of breast carcinomas.

Results: For Luminal A tumors, a partial correlation was detected between MCit and progesterone receptor (PR) (p=0.005). Luminal B tumors showed a significant correlation between MCpt and age (p=0.009), estrogen receptor (ER) (p=0.017) and PR (p=0.035). MCit and MCpt were strongly interrelated in this subtype (p=0.002) and in triple-negative breast cancers (p=0.002). In HER2 subtype, MCpt tumors were significantly correlated with HER2 (p=0.044). In G2 tumors, MCpt correlated with ER (p=0.015) and PR (p=0.038) while in G3 tumors ER correlated with both MCit (p=0.009) and MCpt (p=0.000487) tumors.

Conclusion: MCs dynamics are strongly influenced by hormone receptors and HER2 status. MCit increased in aggressive tumor types and is a worse prognostic factor.

Keywords: Breast cancer; hormone receptors; mast cell; prognosis; tryptase; tumor grade.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers
  • Biomarkers, Tumor
  • Breast Neoplasms / diagnosis*
  • Breast Neoplasms / metabolism*
  • Breast Neoplasms / therapy
  • Combined Modality Therapy
  • Female
  • Humans
  • Immunohistochemistry
  • Mast Cells / immunology*
  • Mast Cells / metabolism*
  • Middle Aged
  • Neoplasm Grading
  • Neovascularization, Pathologic / metabolism
  • Prognosis
  • Treatment Outcome
  • Tumor Microenvironment / immunology*

Substances

  • Biomarkers
  • Biomarkers, Tumor